Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RNA N6-methyladenosine modification is required for miR-98/MYCN axis-mediated inhibition of neuroblastoma progression

12 Aug 2020

Abstract excerpt

Abstract Neuroblastoma (NB) is one of the most common malignant tumors of the sympathetic nervous system in childhood. NB severely threatens patient’s health and life. However, more effective diagnosis and treatment methods are badly needed in clinics all over the world. MYCN is well recognized as a genetic biomarker of high risk and poor outcome in NB. miRNAs are small RNAs and miR-98 involved in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neuroblastoma Research and Treatments
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32788584
DOI: 10.1038/s41598-020-64682-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RNA N6-methyladenosine modification is required for miR-98/MYCN axis-mediated inhibition of neuroblastoma progressionPMID 32788584Read ↗

RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferationSemantic proximity Read ↗

N-myc and Noncoding RNAs in NeuroblastomaSemantic proximity Read ↗

The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targetsSemantic proximity Read ↗

MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolutionSemantic proximity Read ↗

MYCN in Neuroblastoma: “Old Wine into New Wineskins”Semantic proximity Read ↗

METTL14 promotes neuroblastoma by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanismSemantic proximity Read ↗

m6A reader YTHDF1 inhibits the growth of neuroblastoma in vitro and in vivoSemantic proximity Read ↗

Therapeutic targeting of miRNAs in neuroblastomaSemantic proximity Read ↗

MYCN regulates oncogenic MicroRNAs in neuroblastomaSemantic proximity Read ↗

A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in NeuroblastomaSemantic proximity Read ↗

Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for NeuroblastomaSemantic proximity Read ↗

Epigenetic Dysregulation in MYCN-Amplified NeuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.